GCVTX
Price
$25.27
Change
+$0.14 (+0.56%)
Updated
Sep 18 closing price
Net Assets
556.11M
RMEBX
Price
$61.56
Change
+$0.11 (+0.18%)
Updated
Sep 18 closing price
Net Assets
110.88B
Interact to see
Advertisement

GCVTX vs RMEBX

Header iconGCVTX vs RMEBX Comparison
Open Charts GCVTX vs RMEBXBanner chart's image
Goldman Sachs Large Cp Val Insghts I
Price$25.27
Change+$0.14 (+0.56%)
VolumeN/A
Net Assets556.11M
American Funds American Mutual R2E
Price$61.56
Change+$0.11 (+0.18%)
VolumeN/A
Net Assets110.88B
GCVTX vs RMEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GCVTX vs. RMEBX commentary
Sep 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCVTX is a Hold and RMEBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 111B vs. GCVTX (556M). RMEBX (1.09) and GCVTX (1.06) have matching dividends . GCVTX was incepted earlier than RMEBX: GCVTX (18 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than GCVTX (0.77). GCVTX is a more actively managed with annual turnover of: 206.00 vs. RMEBX (31.00). GCVTX has a lower initial minimum investment than RMEBX: GCVTX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 7.43 vs. GCVTX (-3.16). RMEBX return over 5 years is better than : 59.30 vs. GCVTX (35.24).
GCVTXRMEBXGCVTX / RMEBX
Total Expense Ratio0.671.0763%
Annual Report Gross Expense Ratio0.771.0772%
Fund Existence18 years11 years-
Gain YTD9.73112.99475%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets556M111B1%
Annual Yield % from dividends1.061.0997%
Returns for 1 year-3.167.43-42%
Returns for 3 years24.3833.1274%
Returns for 5 years35.2459.3059%
Returns for 10 years77.0594.4082%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BEAT1.590.18
+12.77%
Heartbeam
ENGN6.960.44
+6.75%
enGene Holdings
XOMAP26.540.39
+1.49%
XOMA Corp
GTLB50.04-0.39
-0.77%
GitLab
GRDN26.42-0.75
-2.76%
Guardian Pharmacy Services Inc.